1. Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive;Maciulaitis;Mol Ther,2012
2. Pearce KF, Hildebrandt M, Greinix H, Scheding S, Koehl U, Worel N, et al. The regulation of Advanced Therapy Medicinal Products in Europe and the role of academia. Under revision.
3. Participation of patients in the development of advanced therapy medicinal products;Bignami;Bundesgesundheitsbl,2011
4. Sethe S, Hildebrandt M. Caught in the Gap: ATMP manufacture in academia. ISCT Telegraft 1/2012; 19(1). Available from: http://mediatum.ub.tum.de/doc/1100606/document.pdf.
5. EudraLex Volume 4: EU guidelines for Good Manufacturing Practice for medicinal products for human and veterinary use. Annex 2: manufacture of biological active substances and medicinal products for human use. Ref Ares (2012)778531–28/06/2012. Available from: http://ec.europa.eu/health/documents/eudralex/vol-4/index_en.html.